Clinical

Dataset Information

0

A Study Evaluating TAS-102 Plus Nivolumab in Patients With MSS CRC


ABSTRACT: A Phase 2 Study with Safety Lead-in, Evaluating TAS-102 Plus Nivolumab in Participants with Microsatellite Stable Refractory Metastatic Colorectal Cancer

DISEASE(S): Refractory Metastatic Colorectal Cancer,Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2221915 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2024-08-26 | GSE275628 | GEO
2023-03-31 | GSE226221 | GEO
| 2177942 | ecrin-mdr-crc
| PRJNA752407 | ENA
| PRJNA752408 | ENA
| 2353637 | ecrin-mdr-crc
| PRJNA1170200 | ENA
| S-EPMC8637322 | biostudies-literature
| 92106 | ecrin-mdr-crc
2024-07-29 | GSE248014 | GEO